Transitioning your therapeutic peptide programme from research to clinic
Alastair Hay walks through some of the key considerations facing the transition of peptide therapeutic programmes to clinic.
The field of peptide therapeutics is alive and well, and the landscape has changed to incorporate creative solutions to some of the disadvantages they present as a class of molecule. Giving
consideration to a few concepts can help smooth transition from research to the clinical arena.
Download the article to find out more.View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.